News

11.07.2019

The pharmaceutical industry sees the Finnish EU Presidency as an opportunity to promote the European competitiveness

The pharmaceutical industry sees the Finnish EU Presidency as an opportunity to promote the European competitiveness. The agenda for the forthcoming EU Commission will include important issues related to research, innovations and the industrial policy.

07.06.2019 | Mia Bengtström, Senior Advisor, PIF

Welcome to the 3rd Nordic Conference on Pediatric Medicines 8-9 October 2019 in Helsinki

3rd Nordic conference will facilitate and bring forward ideas for discussion in order to accelerate medicine development for children, by providing most appropriate context for new solutions, and updating the current information related to pediatric Clinical Trials.

03.05.2019

High-quality care calls for enhanced clinical research

Syöpäsäätiö (Cancer Foundation) and thirty-two other research actors provided the parliamentary groups with their appeal for enhanced medical research.

02.05.2019

Pharmaceutical industry’s investments in R&D up over six percent in 2018

In 2018, the R&D investments made by the pharmaceutical industry in Finland grew by over six percent. The aggregate investment of the pharmaceutical industry in research and development in 2018 was over 216 million euro, compared to 201 million euro in the previous year.

25.04.2019

Construction of future healthcare is a collaborative effort

We in the pharmaceutical industry want to contribute to medical breakthroughs and ensure that they are exploited in the best interest of the patients. During the operating year 2018, we set the step marks for the future and drafted our new strategy for the years 2019-2021.

1 2 3